CHICAGO — Two bone turnover markers were significantly lower at 3 months and 1 year in postmenopausal women who received estetrol (E4) compared with patients who received placebo, according to a study ...
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback